Advertisement

What Every Pediatric Gynecologist Should Know About Marijuana Use in Adolescents

  • Nicholas Chadi
    Correspondence
    Address correspondence to: Nicholas Chadi, MD, MPH, Adolescent Substance Use and Addiction Program, Division of Developmental Medicine, Boston Children’s Hospital, 300 Longwood Ave, Boston, MA, USA, 02115; and Department of Pediatrics, Harvard Medical School, 25 Shattuck St, Boston, MA 02115; Phone: 617-355-2727; fax: 617-355-4208
    Affiliations
    Adolescent Substance Use and Addiction Program, Division of Developmental Medicine, Boston Children’s Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA
    Search for articles by this author
  • Sharon Levy
    Affiliations
    Adolescent Substance Use and Addiction Program, Division of Developmental Medicine, Boston Children’s Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA
    Search for articles by this author
Published:March 25, 2019DOI:https://doi.org/10.1016/j.jpag.2019.03.004

      Abstract

      Use of marijuana in adolescent girls is common and shows no sign of decreasing. With recent trends toward legalization of “recreational” and “medical” marijuana products, adolescents are increasingly faced with information and misinformation about the health effects of marijuana use. We review the current literature on the risks and potential benefits of marijuana use during adolescence with a specific focus on pediatric and adolescent gynecological conditions. Despite limited research on this topic, the many risks associated with marijuana use in adolescents, including negative effects on the developing brain and adverse reproductive, sexual health, and mental health outcomes, likely outweigh potential benefits in this population.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Pediatric and Adolescent Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Miech R.A.
        • Schulenberg J.E.
        • Johnston L.D.
        • et al.
        National adolescent drug trends in 2017: Findings released.
        (Available at:)
        • Substance Abuse and Mental Health Services Administration
        Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. HHS Publication No SMA 17-5044 NSH-52.
        Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD2017
        • Sarvet A.L.
        • Wall M.M.
        • Keyes K.M.
        • et al.
        Recent rapid decrease in adolescents’ perception that marijuana is harmful, but no concurrent increase in use.
        Drug Alcohol Depend. 2018; 186: 68
        • Johnson R.M.
        • Fairman B.
        • Gilreath T.
        • et al.
        Past 15-year trends in adolescent marijuana use: differences by race/ethnicity and sex.
        Drug Alcohol Depend. 2015; 155: 8
        • Hsiao R.C.J.
        • Walker L.R.
        Understanding adolescent substance use disorders in the era of marijuana legalization, opioid epidemic, and social media.
        Child Adolesc Psychiatr Clin N Am. 2016; 25 (xiii)
        • Radwan M.M.
        • ElSohly M.A.
        • Slade D.
        • et al.
        Biologically active cannabinoids from high-potency cannabis sativa.
        J Nat Prod. 2009; 72: 906
        • Mechoulam R.
        • Parker L.A.
        The endocannabinoid system and the brain.
        Annu Rev Psychol. 2013; 64: 21
        • Martin-Santos R.
        • Crippa J.A.
        • Batalla A.
        • et al.
        Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.
        Curr Pharm Des. 2012; 18: 4966
        • Grant C.N.
        • Bélanger R.E.
        Cannabis and Canada’s children and youth.
        Paediatr Child Health. 2017; 22: 98
        • Neale M.
        Efficacy and safety of cannabis for treating children with refractory epilepsy.
        Nurs Child Young People. 2017; 29: 32
      1. US Department of Justice Drug Enforcement Administration Diversion Control Division: Title 21 Code of Federal Regulations - Part 1308 - Schedules of Controlled Substances. Drug Enforcement Administration: Springfield, VA.

        • Vandrey R.
        • Raber J.C.
        • Raber M.E.
        • et al.
        Cannabinoid dose and label accuracy in edible medical cannabis products.
        JAMA. 2015; 313: 2491
        • Ohannessian C.M.
        • Finan L.J.
        • Schulz J.
        • et al.
        A long-term longitudinal examination of the effect of early onset of alcohol and drug use on later alcohol abuse.
        Subst Abus. 2015; 36: 440
        • Jacobus J.
        • Tapert S.F.
        Effects of cannabis on the adolescent brain.
        Curr Pharm Des. 2014; 20: 2186
        • Volkow N.D.
        • Swanson J.M.
        • Evins A.E.
        • et al.
        Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review.
        JAMA Psychiatry. 2016; 73: 292
        • Bagot K.S.
        • Milin R.
        • Kaminer Y.
        Adolescent initiation of cannabis use and early-onset psychosis.
        Subst Abus. 2015; 36: 524
      2. The national academies of sciences engineering and medicine: The health effects of Cannabis and Cannabinoids: The current state of evidence and recommendations for research.
        (Available at:)
        • Lowe D.J.E.
        • Sasiadek J.D.
        • Coles A.S.
        • et al.
        Cannabis and mental illness: a review.
        Eur Arch Psychiatry Clin Neurosci. 2019; 269: 107
        • Orr C.
        • Spechler P.
        • Cao Z.
        • et al.
        Grey matter volume differences associated with extremely low levels of cannabis use in adolescence.
        J Neurosci. 2019; 39: 1817
        • Cooper Z.D.
        • Craft R.M.
        Sex-dependent effects of cannabis and cannabinoids: a translational perspective.
        Neuropsychopharmacology. 2018; 43: 34
        • Ehlers C.L.
        • Gizer I.R.
        • Vieten C.
        • et al.
        Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability.
        Addict Behav. 2010; 35: 102
        • Levy S.
        • Wetizman E.R.
        Association of acute mental health symptoms with frequency of marijuana use in adolescents.
        JAMA Pediatr. 2019; 173: 185
        • Cooper M.
        • Loukas A.
        • Harrell M.B.
        • et al.
        College students’ perceptions of risk and addictiveness of e-cigarettes and cigarettes.
        J Am Coll Health. 2017; 65: 103
        • ElSohly M.A.
        • Mehmedic Z.
        • Foster S.
        • et al.
        Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States.
        Biol Psychiatry. 2016; 79: 613
        • Kimmel H.L.
        • Lopez M.F.
        Cannabis use disorder: recent findings and future directions.
        Curr Addict Rep. 2018; 5: 397
        • Simpson A.K.
        • Magid V.
        Cannabis use disorder in adolescence.
        Child Adolesc Psychiatr Clin N Am. 2016; 25: 431
        • Bonnet U.
        • Preuss U.
        The cannabis withdrawal syndrome: current insights.
        Subst Abuse Rehabil. 2017; 8: 9
        • Russo E.
        Cannabis treatments in obstetrics and gynecology: a historical review.
        J Cannabis Ther. 2002; 2: 5
        • Boyd C.J.
        • Veliz P.T.
        • McCabe S.E.
        Adolescents’ use of medical marijuana: a secondary analysis of monitoring the future data.
        J Adolesc Health. 2015; 57: 241
        • Wong S.S.
        • Wilens T.E.
        Medical cannabinoids in children and adolescents: a systematic review.
        Pediatrics. 2017; 140: e20171818
        • Woodhams S.G.
        • Sagar D.R.
        • Burston J.J.
        • et al.
        The role of the endocannabinoid system in pain.
        Handbook of Experimental Pharmacology. 227. 2015: 119
        • Nickel J.C.
        Medical marijuana for urologic chronic pelvic pain.
        Can Urol Assoc J. 2018; 12: S181
        • Harrison T.E.
        • Bruce B.K.
        • Weiss K.E.
        • et al.
        Marijuana and chronic nonmalignant pain in adolescents.
        Mayo Clin Proc. 2013; 88: 647
        • Bouaziz J.
        • Bar On A.
        • Seidman D.S.
        • et al.
        The clinical significance of endocannabinoids in endometriosis pain management.
        Cannabis Cannabinoid Res. 2017; 2: 72
        • Leconte M.
        • Nicco C.
        • Ngô C.
        • et al.
        Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis.
        Am J Pathol. 2010; 177: 2963
        • McHugh D.
        • Page J.
        • Dunn E.
        • et al.
        Δ(9)-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells.
        Br J Pharmacol. 2012; 165: 2414
        • Tartaglia E.
        • Armentano M.
        • Giugliano B.
        • et al.
        Effectiveness of the Association N-palmitoylethanolamine and transpolydatin in the treatment of primary dysmenorrhea.
        J Pediatr Adolesc Gynecol. 2015; 28: 447
        • Slavin M.
        • Barach E.
        • Farmer S.
        • et al.
        Cannabis and symptoms of PMS and PMDD.
        Addict Res Theory. 2017; 25: 383
        • Grinspoon L.
        • Bakalar J.B.
        Marihuana, the Forbidden Medicine.
        Yale University Press, New Haven, CT1997
        • Brents L.K.
        Marijuana, the endocannabinoid system and the female reproductive system.
        Yale J Biol Med. 2016; 89: 175
        • Smith C.G.
        • Almirez R.G.
        • Berenberg J.
        • et al.
        Tolerance develops to the disruptive effects of delta 9-tetrahydrocannabinol on primate menstrual cycle.
        Science. 1983; 219: 1453
        • Lammert S.
        • Harrison K.
        • Tosun N.
        • et al.
        Menstrual cycle in women who co-use marijuana and tobacco.
        J Addict Med. 2018; 12: 207
        • Griffin M.L.
        • Mendelson J.H.
        • Mello N.K.
        • et al.
        Marihuana use across the menstrual cycle.
        Drug Alcohol Depend. 1986; 18: 213
        • Watanabe K.
        • Yamaori S.
        • Funahashi T.
        • et al.
        Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes.
        Life Sci. 2007; 80: 1415
        • Agrawal A.
        • Few L.
        • Nelson E.C.
        • et al.
        Adolescent cannabis use and repeated voluntary unprotected sex in women.
        Addiction. 2016; 111: 2012
        • Keen L.
        • Blanden G.
        • Rehmani N.
        Lifetime marijuana use and sexually transmitted infection history in a sample of Black college students.
        Addict Behav. 2016; 60: 203
        • American College of Obstetricians and Gynecologists
        Marijuana use during pregnancy and lactation.
        (Available at:)
        • El Marroun H.
        • Brown Q.L.
        • Lund I.O.
        • et al.
        An epidemiological, developmental and clinical overview of cannabis use during pregnancy.
        Prev Med. 2018; 116: 1
        • Brown Q.L.
        • Sarvet A.L.
        • Shmulewitz D.
        • et al.
        Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002-2014.
        JAMA. 2017; 317: 207
        • Metz T.D.
        • Stickrath E.H.
        Marijuana use in pregnancy and lactation: a review of the evidence.
        Am J Obstet Gynecol. 2015; 213: 761
        • Dotters-Katz S.K.
        • Smid M.C.
        • Manuck T.A.
        • et al.
        Risk of neonatal and childhood morbidity among preterm infants exposed to marijuana.
        J Matern Neonatal Med. 2017; 30: 2933
        • Merlob P.
        • Stahl B.
        • Klinger G.
        For debate: does cannabis use by the pregnant mother affect the fetus and newborn?.
        Pediatr Endocrinol Rev. 2017; 15: 4
        • Bergeria C.L.
        • Heil S.H.
        Surveying lactation professionals regarding marijuana use and breastfeeding.
        Breastfeed Med. 2015; 10: 377
        • Tarragon E.
        • Moreno J.J.
        Cannabinoids, chemical senses, and regulation of feeding behavior.
        Chem Senses. 2019; 44: 73
        • Chesney T.
        • Matsos L.
        • Couturier J.
        • et al.
        Cannabis withdrawal syndrome: an important diagnostic consideration in adolescents presenting with disordered eating.
        Int J Eat Disord. 2014; 47: 219
        • Jin L.Z.
        • Rangan A.
        • Mehlsen J.
        • et al.
        Association between use of cannabis in adolescence and weight change into midlife.
        PLoS One. 2017; 12: e0168897
        • Lapoint J.
        • Meyer S.
        • Yu C.K.
        • et al.
        Cannabinoid hyperemesis syndrome: public health implications and a novel model treatment guideline.
        West J Emerg Med. 2018; 19: 380
        • Desjardins N.
        • Jamoulle O.
        • Taddeo D.
        • et al.
        Cannabinoid hyperemesis syndrome in a 17-year-old adolescent.
        J Adolesc Health. 2015; 57: 565
        • Levy S.
        • Ziemnik R.E.
        • Harris S.K.
        • et al.
        Screening adolescents for alcohol use: tracking practice trends of Massachusetts pediatricians.
        J Addict Med. 2017; 11: 427
        • Levy S.J.
        • Williams J.F.
        Committee on Substance Use and Prevention: Substance use screening, brief intervention, and referral to treatment.
        Pediatrics. 2016; 138: e20161211
        • Levy S.
        • Weiss R.
        • Sherritt L.
        • et al.
        An electronic screen for triaging adolescent substance use by risk levels.
        JAMA Pediatr. 2014; 168: 822
        • Chadi N.
        • Bagley S.M.
        • Hadland S.E.
        Addressing adolescents’ and young adults’ substance use disorders.
        Med Clin North Am. 2018; 102: 603